Patients in each arm have the option of getting a treatment that the FDA says is already proven to extend survival (Taxotere). So to the FDA, this satisfies the ethics question.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.